Kura Oncology (KURA) News Today $9.85 -0.40 (-3.90%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$10.00 +0.15 (+1.52%) As of 10/10/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KURA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Menin Inhibitors Drug Market Report 2025: Price, Sales & Clinical Trials Insights 2024-2028 - Kura Oncology & Kyowa Kirin Progress with New Drug ApplicationsOctober 10 at 9:49 AM | finance.yahoo.comKura Oncology (NASDAQ:KURA) Rating Lowered to Strong Sell at Zacks ResearchOctober 10 at 9:08 AM | marketbeat.comKura Oncology (NASDAQ:KURA) Given "Sell (D-)" Rating at Weiss RatingsOctober 10 at 6:51 AM | marketbeat.comKura Oncology (NASDAQ:KURA) Trading 8.9% Higher - Still a Buy?October 8, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Buys 35,779 Shares of Kura Oncology, Inc. $KURAOctober 8, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives $24.10 Consensus Price Target from AnalystsOctober 4, 2025 | americanbankingnews.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 3, 2025 | markets.businessinsider.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 3, 2025 | globenewswire.comKura Oncology, Inc. (KURA) Presents at UBS Virtual Oncology Day TranscriptOctober 1, 2025 | seekingalpha.comKura Oncology, Kyowa Kirin doses first patient of KOMET-007 trialOctober 1, 2025 | msn.comKura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)October 1, 2025 | globenewswire.comKura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of "Moderate Buy" by BrokeragesOctober 1, 2025 | marketbeat.comHC Wainwright & Co. Reiterates Kura Oncology (KURA) Buy RecommendationSeptember 30, 2025 | msn.comKura Oncology's (KURA) "Buy" Rating Reaffirmed at HC WainwrightSeptember 30, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) SVP Sells $40,596.54 in StockSeptember 30, 2025 | insidertrades.comKura Oncology announces first patient dosed in KOMET-017 clinical trialSeptember 29, 2025 | msn.comKura Oncology (NASDAQ:KURA) SVP Thomas James Doyle Sells 4,541 SharesSeptember 29, 2025 | marketbeat.comKathleen Ford Sells 6,892 Shares of Kura Oncology (NASDAQ:KURA) StockSeptember 29, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Insider Teresa Brophy Bair Sells 8,805 SharesSeptember 29, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Insider Brian Powl Sells 8,891 SharesSeptember 29, 2025 | marketbeat.comInsider Selling: Kura Oncology (NASDAQ:KURA) Insider Sells 12,314 Shares of StockSeptember 29, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) CEO Sells $327,338.10 in StockSeptember 29, 2025 | marketbeat.comKura Oncology and Kyowa Kirin Announce First Patient Dosed in Pivotal Phase 3 KOMET-017 Trial of Ziftomenib for Frontline Acute Myeloid Leukemia (AML)September 29, 2025 | globenewswire.comKura Oncology (NASDAQ:KURA) Shares Up 6.4% - Here's WhySeptember 26, 2025 | marketbeat.comKura Oncology’s ziftomenib meets primary endpoint in AML studySeptember 25, 2025 | msn.comKura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical OncologySeptember 25, 2025 | globenewswire.comKura Oncology to Participate in Upcoming Investor ConferenceSeptember 24, 2025 | globenewswire.comKura Oncology Insider Ups Holding During YearSeptember 21, 2025 | finance.yahoo.comKura Oncology Transitioning To Commercial Stage: Why I Choose To BuySeptember 19, 2025 | seekingalpha.comGoldman Sachs Group Inc. Sells 34,304 Shares of Kura Oncology, Inc. $KURASeptember 17, 2025 | marketbeat.comAcadian Asset Management LLC Takes $2.18 Million Position in Kura Oncology, Inc. $KURASeptember 17, 2025 | marketbeat.comKura Oncology, Inc. - Special CallSeptember 16, 2025 | seekingalpha.comKura Oncology, Inc. (KURA) Discusses On FTI Preclinical Program Review: Synergistic Combinations With Targeted Therapies Conference TranscriptSeptember 16, 2025 | seekingalpha.comKura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies ...September 16, 2025 | markets.businessinsider.comKura Oncology Highlights KO-2806 Opportunities at Analyst/Investor Event Ahead of ESMO Congress 2025September 16, 2025 | quiverquant.comQKura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor TypesSeptember 16, 2025 | globenewswire.comAQR Capital Management LLC Boosts Stock Position in Kura Oncology, Inc. $KURASeptember 15, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Trading Down 4.1% - Here's WhySeptember 14, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Shares Gap Up After Insider Buying ActivitySeptember 12, 2025 | marketbeat.comTroy Edward Wilson Acquires 50,000 Shares of Kura Oncology (NASDAQ:KURA) StockSeptember 11, 2025 | marketbeat.comKura Oncology, Inc. (KURA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 10, 2025 | seekingalpha.comKura Oncology (NASDAQ:KURA) CEO Troy Edward Wilson Buys 50,000 SharesSeptember 10, 2025 | insidertrades.comKura Oncology, Inc. $KURA Shares Bought by Jacobs Levy Equity Management Inc.September 10, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Rating of "Moderate Buy" from BrokeragesSeptember 8, 2025 | marketbeat.comLifeSci Capital Maintains Buy Rating on Kura Oncology (KURA)September 8, 2025 | insidermonkey.comEcoR1 Capital LLC Sells 916,971 Shares of Kura Oncology, Inc. $KURASeptember 6, 2025 | marketbeat.comKura Oncology, Inc. $KURA Stake Raised by Graham Capital Management L.P.September 6, 2025 | marketbeat.comIeq Capital LLC Buys Shares of 97,931 Kura Oncology, Inc. $KURASeptember 6, 2025 | marketbeat.comKura Flat on Inducement AwardsSeptember 5, 2025 | baystreet.caKura Oncology (NASDAQ:KURA) Trading 5% Higher - What's Next?September 5, 2025 | marketbeat.com Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KURA Media Mentions By Week KURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼0.590.77▲Average Medical News Sentiment KURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼87▲KURA Articles Average Week Get the Latest News and Ratings for KURA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Kura Oncology and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AMRX News CNTA News XENE News CGON News QURE News RARE News APLS News IMVT News OGN News MOR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 2025 Market Crash?Wall Street Legend Names #1 Stock [not NVDA] The greatest quantitative mind on Wall Street just revealed hi...Chaikin Analytics | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
